Els Goetghebeur

Els Goetghebeur

Universiteit Gent

H-index: 46

Europe-Belgium

About Els Goetghebeur

Els Goetghebeur, With an exceptional h-index of 46 and a recent h-index of 24 (since 2020), a distinguished researcher at Universiteit Gent, specializes in the field of Statistics, health, causal inference, survival.

His recent articles reflect a diverse array of research interests and contributions to the field:

Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation

Evaluation of tuberculosis diagnostic test accuracy using Bayesian latent class analysis in the presence of conditional dependence between the diagnostic tests used in a …

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors: the CHEERS phase 2 randomized clinical trial

Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI …

Causal inference in survival analysis under deterministic missingness of confounders in register data

Propensity score weighting plus an adjusted proportional hazards model does not equal doubly robust away from the null

Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice

PEACE V—Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): acute toxicity of a randomized phase 2 trial

Els Goetghebeur Information

University

Position

___

Citations(all)

7320

Citations(since 2020)

3109

Cited By

5415

hIndex(all)

46

hIndex(since 2020)

24

i10Index(all)

93

i10Index(since 2020)

46

Email

University Profile Page

Universiteit Gent

Google Scholar

View Google Scholar Profile

Els Goetghebeur Skills & Research Interests

Statistics

health

causal inference

survival

Top articles of Els Goetghebeur

Title

Journal

Author(s)

Publication Date

Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation

Statistics in Medicine

Erin E Gabriel

Michael C Sachs

Torben Martinussen

Ingeborg Waernbaum

Els Goetghebeur

...

2024/2/10

Evaluation of tuberculosis diagnostic test accuracy using Bayesian latent class analysis in the presence of conditional dependence between the diagnostic tests used in a …

Plos one

Alfred Kipyegon Keter

Lutgarde Lynen

Alastair Van Heerden

Emily Wong

Klaus Reither

...

2023/3/2

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors: the CHEERS phase 2 randomized clinical trial

JAMA oncology

Mathieu Spaas

Nora Sundahl

Vibeke Kruse

Sylvie Rottey

Daan De Maeseneer

...

2023/9/1

Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI …

Madeline Pe

Ahu Alanya

Ragnhild Sorum Falk

Cecilie Delphin Amdal

Kristin Bjordal

...

2023/6/1

Causal inference in survival analysis under deterministic missingness of confounders in register data

Statistics in Medicine

Iuliana Ciocănea‐Teodorescu

Els Goetghebeur

Ingeborg Waernbaum

Staffan Schön

Erin E Gabriel

2023/5/30

Propensity score weighting plus an adjusted proportional hazards model does not equal doubly robust away from the null

arXiv preprint arXiv:2310.16207

Erin E Gabriel

Michael C Sachs

Ingeborg Waernbaum

Els Goetghebeur

Paul F Blanche

...

2023/10/24

Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice

Limin Liu

Jungyeon Choi

Jammbe Z Musoro

Willi Sauerbrei

Cecilie Delphin Amdal

...

2023/5/1

PEACE V—Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): acute toxicity of a randomized phase 2 trial

European urology oncology

Piet Ost

Shankar Siva

Sigmund Brabrand

Piet Dirix

Nick Liefhooghe

...

2023/10/9

Implications of covariate induced test dependence on the diagnostic accuracy of latent class analysis in pulmonary tuberculosis

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Alfred Kipyegon Keter

Lutgarde Lynen

Alastair Van Heerden

Els Goetghebeur

Bart KM Jacobs

2022/12/1

PEACE V-STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity

T Zilli

S Siva

R Heikkila

P Dirix

N Liefhooghe

...

2022

Motion-control shoes reduce the risk of pronation-related pathologies in recreational runners: a secondary analysis of a randomized controlled trial

journal of orthopaedic & sports physical therapy

Tine Marieke Willems

Christophe Ley

Els Goetghebeur

Daniel Theisen

Laurent Malisoux

2021/3

Framework for the treatment and reporting of missing data in observational studies: the treatment and reporting of missing data in observational studies framework

Journal of clinical epidemiology

Katherine J Lee

Kate M Tilling

Rosie P Cornish

Roderick JA Little

Melanie L Bell

...

2021/6/1

Intraperitoneal aerosolization of albumin-bound paclitaxel nanoparticles (Abraxane®) for peritoneal metastasis: a phase I first-in-human study

European Journal of Surgical Oncology

Leen Van de Sande

M Graversen

A Vermeulen

D Reynders

E Goetghebeur

...

2021/2/1

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled …

BMC cancer

Mathieu Spaas

Nora Sundahl

Eva Hulstaert

Vibeke Kruse

Sylvie Rottey

...

2021/5/7

Reply to ‘Low‐dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID‐19: association does not mean causality’

International journal of antimicrobial agents

Nicolas Dauby

Lucy Catteau

Joris Hautekiet

Marion Montourcy

Emmanuel Bottieau

...

2021/2

Consistency of causal claims in observational studies: a review of papers published in a general medical journal

Camila Olarte Parra

Lorenzo Bertizzolo

Sara Schroter

Agnès Dechartres

Els Goetghebeur

2021/5/1

Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification

BMC cancer

Maria Olsen

Krista Fischer

Patrick M Bossuyt

Els Goetghebeur

2021/12

Immuno-radiotherapy in solid tumors: preliminary results of the randomized phase 2 CHEERS trial

Mathieu Spaas

Nora Sundahl

Sylvie Rottey

VIBEKE KRUSE

Daan De Maeseneer

...

2021

Reply to “The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of ‘goals of care’”

International journal of antimicrobial agents

Nicolas Dauby

Joris Hautekiet

Lucy Catteau

Marion Montourcy

Dominique Van Beckhoven

...

2021/4

A framework for meta-analysis through standardized survival curves

arXiv preprint arXiv:2111.13132

Joris Hautekiet

Elena-Sophie Prigge

Theresa Obermueller

Marc Arbyn

Els Goetghebeur

2021/11/25

See List of Professors in Els Goetghebeur University(Universiteit Gent)